JP2020143129A5 - - Google Patents

Download PDF

Info

Publication number
JP2020143129A5
JP2020143129A5 JP2020090240A JP2020090240A JP2020143129A5 JP 2020143129 A5 JP2020143129 A5 JP 2020143129A5 JP 2020090240 A JP2020090240 A JP 2020090240A JP 2020090240 A JP2020090240 A JP 2020090240A JP 2020143129 A5 JP2020143129 A5 JP 2020143129A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
compound according
compound
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020090240A
Other languages
English (en)
Japanese (ja)
Other versions
JP7058885B2 (ja
JP2020143129A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020143129A publication Critical patent/JP2020143129A/ja
Publication of JP2020143129A5 publication Critical patent/JP2020143129A5/ja
Priority to JP2022063260A priority Critical patent/JP2022092625A/ja
Application granted granted Critical
Publication of JP7058885B2 publication Critical patent/JP7058885B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020090240A 2013-06-11 2020-05-25 尿素誘導体及びその使用 Active JP7058885B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022063260A JP2022092625A (ja) 2013-06-11 2022-04-06 尿素誘導体及びその使用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361833853P 2013-06-11 2013-06-11
US61/833,853 2013-06-11
US201361898720P 2013-11-01 2013-11-01
US61/898,720 2013-11-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019004872A Division JP2019070027A (ja) 2013-06-11 2019-01-16 尿素誘導体及びその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022063260A Division JP2022092625A (ja) 2013-06-11 2022-04-06 尿素誘導体及びその使用

Publications (3)

Publication Number Publication Date
JP2020143129A JP2020143129A (ja) 2020-09-10
JP2020143129A5 true JP2020143129A5 (enExample) 2021-02-25
JP7058885B2 JP7058885B2 (ja) 2022-04-25

Family

ID=52022933

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016519614A Expired - Fee Related JP6469661B2 (ja) 2013-06-11 2014-06-11 尿素誘導体及びその使用
JP2019004872A Pending JP2019070027A (ja) 2013-06-11 2019-01-16 尿素誘導体及びその使用
JP2020090240A Active JP7058885B2 (ja) 2013-06-11 2020-05-25 尿素誘導体及びその使用
JP2022063260A Pending JP2022092625A (ja) 2013-06-11 2022-04-06 尿素誘導体及びその使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016519614A Expired - Fee Related JP6469661B2 (ja) 2013-06-11 2014-06-11 尿素誘導体及びその使用
JP2019004872A Pending JP2019070027A (ja) 2013-06-11 2019-01-16 尿素誘導体及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022063260A Pending JP2022092625A (ja) 2013-06-11 2022-04-06 尿素誘導体及びその使用

Country Status (6)

Country Link
US (9) US9212145B2 (enExample)
EP (1) EP3030239A4 (enExample)
JP (4) JP6469661B2 (enExample)
AU (3) AU2014278231B2 (enExample)
CA (1) CA2914815A1 (enExample)
WO (1) WO2014201127A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3030239A4 (en) 2013-06-11 2017-03-08 Kala Pharmaceuticals, Inc. Urea derivatives and uses thereof
CA2969467A1 (en) 2014-12-10 2016-06-16 Kala Pharmaceuticals, Inc. 1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
CA3005723A1 (en) * 2015-11-20 2017-05-26 Mingsight Pharmaceuticals, Inc. Treatment of autoimmune disease
CN110167554B (zh) * 2016-11-17 2023-05-23 思路迪(北京)医药科技有限公司 一种具有抗癌作用的化合物及其制备方法和应用
EP4079303A4 (en) * 2019-12-16 2023-08-23 Suzhou Raymon Pharmaceuticals Company, Ltd. USE OF A NAPHTHYLUREA COMPOUND
WO2021138434A1 (en) * 2019-12-31 2021-07-08 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
HUE068185T2 (hu) 2020-05-08 2024-12-28 Halia Therapeutics Inc NEK7-kináz inhibitorok
CN115487183B (zh) * 2021-06-18 2024-07-26 苏州锐明新药研发有限公司 萘脲类化合物在制备治疗翼状胬肉的药物中的应用
JP2025538351A (ja) * 2022-12-13 2025-11-28 スーチョウ レイモン ファーマシューティカルズ カンパニー リミテッド 翼状片の治療の医薬の調製におけるナフチルウレア系化合物の使用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
JPH0959276A (ja) * 1995-08-11 1997-03-04 Kumiai Chem Ind Co Ltd 縮合ヘテロ環誘導体及び除草剤
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
EP1545514A1 (en) 2002-08-14 2005-06-29 Boehringer Ingelheim Pharmaceuticals Inc. Anticoagulant and fibrinolytic therapy using p38 map kinase inhibitors
US7297709B2 (en) * 2003-05-22 2007-11-20 Abbott Laboratories Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
PT1638941E (pt) * 2003-05-22 2010-08-24 Abbott Lab Inibidores de quinases de indazole, benzisoxazole e benzisotiazole
EP1683796A1 (en) * 2005-01-24 2006-07-26 Schering Aktiengesellschaft Pyrazolopyridines, their preparation and their medical use
TW200640443A (en) * 2005-02-23 2006-12-01 Alcon Inc Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
WO2008080110A1 (en) * 2006-12-21 2008-07-03 Alcon, Inc. Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor
CN101239978A (zh) * 2008-03-05 2008-08-13 南方医科大学 一种咪唑并吡啶类化合物
JP2013508295A (ja) * 2009-10-16 2013-03-07 デューク・ユニヴァーシティ 薬物誘発性手足症候群を治療するための組成物および方法
WO2012003141A1 (en) * 2010-07-02 2012-01-05 Alcon Research, Ltd. Compounds for the treatment of posterior segment disorders and diseases
AU2011323250B2 (en) 2010-11-05 2015-11-19 The Johns Hopkins University Compositions and methods relating to reduced mucoadhesion
WO2012158810A1 (en) 2011-05-17 2012-11-22 Principia Biopharma Inc. Tyrosine kinase inhibitors
EP3030239A4 (en) 2013-06-11 2017-03-08 Kala Pharmaceuticals, Inc. Urea derivatives and uses thereof

Similar Documents

Publication Publication Date Title
JP2020143129A5 (enExample)
JP2010501478A5 (enExample)
AU2014222641B2 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of Hepatitis B
JP2014510774A5 (enExample)
JP2018515495A5 (enExample)
JP2009534468A5 (enExample)
JP2008510828A5 (enExample)
BR112014003245B1 (pt) Composto de ácido n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil] acetamida metanossulfônico monohidratado cristalino, método para a sintetização do mesmo, e composição farmacêutica contendo o mesmo
JP2022000421A5 (enExample)
JP2015503527A5 (enExample)
JP2020500869A5 (enExample)
JP2017527578A5 (enExample)
WO2010059922A1 (en) Pyrrolidine carboxamide compounds
MX2011007864A (es) Isosteros para realzar la transcripcion y su uso en terapia.
DK1786790T3 (da) Oxazolderivater som histamin H3 receptorstoffer, fremstilling og terapeutiske anvendelser
JP2013515037A5 (enExample)
JP2012528839A5 (enExample)
JP2010506919A5 (enExample)
JP2020516616A5 (enExample)
RU2021132394A (ru) Кристаллическая фумаратная соль (s)-[3,4-дифтор-2-(2-фтор-4-йодфениламино)фенил][3-гидрокси-3-(пиперидин-2-ил)азетидин-1-ил]метанона
CY1111744T1 (el) Τροποποιητες της δραστηριοτητας toy υποδοχεα χημειοκινων, κρυσταλλικες μορφες και διεργασια
JP2005511594A5 (enExample)
JP2019510801A5 (enExample)
JP2009501745A5 (enExample)
RU2007116987A (ru) Новые соединения